Natural History and Management of Intraductal Papillary Mucinous Neoplasms: Current Evidence.
BACKGROUND
With the use of modern cross-sectional abdominal imaging modalities, an increasing number of cystic pancreatic lesions are identified incidentally. Although there is no pathological diagnosis available in most cases, it is believed that the majority of these lesions display small branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) of the pancreas. Even though a number of large clinical series have been published, many uncertainties remain with regard to this entity of mucinous cystic neoplasms.


METHODS
Systematic literature review.


RESULTS
Main-duct (MD) and mixed-type IPMNs harbor a high risk of malignant transformation. It is conceivable that most IPMNs with involvement of the main duct tend to progress to invasive carcinoma over time. Thus, formal oncologic resection is the treatment of choice in surgically fit patients. In contrast, the data regarding BD-IPMN remain equivocal, resulting in conflicting concepts. To date, it is not clear whether and which BD-IPMNs progress to carcinoma and how long this progression takes.


CONCLUSIONS
While patients with MD-IPMNs should undergo surgical resection if comorbidities and life expectancy permit this, the management of small BD-IPMNs remains controversial. Population-based studies with long-term follow-up are needed to define which cohort of patients can be observed safely without immediate resection.
Department of General, Visceral and Transplantation Surgery, Ruprecht-Karls University of Heidelberg, Heidelberg, Germany.
Stefan
S
Fritz
Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Markus M
MM
Lerch
Cancerogenesis; IPMN; Intraductal papillary mucinous neoplasm; Malignant transformation; Natural history; Pancreas